ArticleFrontiers in oncology2019

Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma.

Didier Dréau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.